Biological CVD Risk Factors in Older Depressed Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine if improvements in mood will ameliorate autonomic dysregulation, HPA dysfunction and typical (e.g. lipids) and atypical risk factors in depressed patients with elevated cardiovascular risk (CVD). Up to 70, depressed participants with elevated cardiovascular risk factors were randomized to a cognitive behavioral intervention (CBT) or a waiting list control (WLC) condition. Twenty non-depressed age and risk-matched controls will also recruited. Traditional risk factors (e.g. lipids, blood pressure, heart rate), atypical risk factors (endothelial function, asymmetric dimethylarginine, C-reactive protein) will be measured pre and post treatment six months later Subjects will undergo a psychophysiological stress test while cardiovascular physiology was measured. Salivary cortisol will be measured during the day and during the psychological stress test. Depressed subjects will be randomized to a 16 week cognitive behavior therapy intervention or to a wait-list control. It is hypothesized that reduction in mood will be associated with reduction in typical and atypical risk factors.
| Condition | Intervention |
|---|---|
|
Depression Hypertension Hypercholesterolemia |
Behavioral: Cognitive behavioral therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Bio-equivalence Study Intervention Model: Single Group Assignment Masking: Double-Blind Primary Purpose: Treatment |
| Official Title: | Stress, the HPA and Health in Aging |
- Change in depression
- Change in typical and atypical risk factors
| Estimated Enrollment: | 70 |
| Study Start Date: | June 2002 |
| Estimated Study Completion Date: | July 2005 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | 55 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age > 55 years, hypertensive or hypercholesterolemic, depressed
Exclusion Criteria:
- suicidal
Contacts and Locations| United States, California | |
| Stanford Medical Center | |
| Stanford, California, United States, 94305 | |
| Principal Investigator: | Craig B Taylor | Stanford Medical Center |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00318864 History of Changes |
| Other Study ID Numbers: | CBarrTaylor, 5 p01 AG18784-02 |
| Study First Received: | April 25, 2006 |
| Last Updated: | April 25, 2006 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Stanford University:
|
depression cardiovascular risk mechanisms |
Additional relevant MeSH terms:
|
Depression Depressive Disorder Hypercholesterolemia Hypertension Behavioral Symptoms Mood Disorders Mental Disorders |
Hyperlipidemias Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on June 18, 2013